Brief: India's Lasa Supergenerics Begins Trial Production At Chiplun
27/11/2017 05:57
Nov 27 (Reuters) - Lasa Supergenerics Ltd LASA.NS :
* BEGINS TRIAL PRODUCTION AT CO'S UNIT IV AT CHIPLUN
Source text - http://bit.ly/2k28Oct
Further company coverage: LASA.NS
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Lasa Supergenerics
See all newsBrief: Lasa Supergenerics Provides Update On Fire Incident
Brief: Lasa Supergenerics Approves Rights Issue To Raise Up To 490 Mln Rupees
Brief: Lasa Supergenerics To Consider Issue Of Warrants Convertible Into Equity Shares
India's Lasa Supergenerics gains after settlement of dues
Brief: Lasa Supergenerics Says Dispute With Bank Of Baroda Settled